Announcements Trials

Browse Landscape

Status

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Gastrointestinal 1 Breast 1

Conditions

Appendiceal Neoplasms 1 Adenocarcinoma, Mucinous 1

Interventions

Oxaliplatin 1004 Fluorouracil 800 Capecitabine 765 Gemcitabine 651 Leucovorin 559 Irinotecan 537 Bevacizumab 513 Radiotherapy 460 Cisplatin 441 Drug Therapy 298 Cetuximab 280 Surgical Procedures, Operative 229 Paclitaxel 228 S 1 (combination) 218 pembrolizumab 206 Docetaxel 199 130-nm albumin-bound paclitaxel 196 Nivolumab 193 sintilimab 191 Radiosurgery 190 lenvatinib 181 Folfox protocol 179 Sorafenib 178 Albumin-Bound Paclitaxel 173 apatinib 170 tislelizumab 161 camrelizumab 160 Neoadjuvant Therapy 158 Blood Specimen Collection 154 durvalumab 148

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × DNA Fingerprinting × Gastrointestinal × Clear all

NCT05734430 2025-04-18

GAP

Vanderbilt-Ingram Cancer Center

Gastrointestinal

Appendiceal Neoplasms, Adenocarcinoma, Mucinous

Data powered by HemOnc (CC BY 4.0) Colophon ⚡